...
首页> 外文期刊>Immunology: An Official Journal of the British Society for Immunology >CD8 T-cell responses against the immunodominant Theileria parva peptide Tp2(49-59) are composed of two distinct populations specific for overlapping 11-mer and 10-mer epitopes
【24h】

CD8 T-cell responses against the immunodominant Theileria parva peptide Tp2(49-59) are composed of two distinct populations specific for overlapping 11-mer and 10-mer epitopes

机译:CD8 T细胞对免疫支原体泰勒菌小体肽Tp2(49-59)的反应由两个不同的群体组成,这些群体对重叠的11-mer和10-mer表位具有特异性

获取原文
获取原文并翻译 | 示例
           

摘要

Immunity against Theileria parva is associated with CD8 T-cell responses that exhibit immunodominance, focusing the response against limited numbers of epitopes. As candidates for inclusion in vaccines, characterization of responses against immunodominant epitopes is a key component in novel vaccine development. We have previously demonstrated that the Tp2(49-59) and Tp1(214-224) epitopes dominate CD8 T-cell responses in BoLA-A10 and BoLA-18 MHC I homozygous animals, respectively. In this study, peptide-MHC I tetramers for these epitopes, and a subdominant BoLA-A10-restricted epitope (Tp2(98-106)), were generated to facilitate accurate and rapid enumeration of epitope-specific CD8 T cells. During validation of these tetramers a substantial proportion of Tp2(49-59)-reactive T cells failed to bind the tetramer, suggesting that this population was heterogeneous with respect to the recognized epitope. We demonstrate that Tp2(50-59) represents a distinct epitope and that tetramers produced with Tp(50-59) and Tp(49-59) show no cross-reactivity. The Tp2(49-59) and Tp2(50-59) epitopes use different serine residues as the N-terminal anchor for binding to the presenting MHC I molecule. Molecular dynamic modelling predicts that the two peptide-MHC I complexes adopt structurally different conformations and Tcell receptor sequence analysis showed that Tp2(49-59) and Tp2(50-59) are recognized by non-overlapping T-cell receptor repertoires. Together these data demonstrate that although differing by only a single residue, Tp2(49-59) and Tp2(50-59) epitopes form distinct ligands for T-cell receptor recognition. Tetramer analysis of T. parva-specific CD8 T-cell lines confirmed the immunodominance of Tp1(214-224) in BoLA-A18 animals and showed in BoLA-A10 animals that the Tp2(49-59) epitope response was generally more dominant than the Tp2(50-59) response and confirmed that the Tp2(98-106) response was subdominant.
机译:针对Theileria parva的免疫力与表现出免疫优势的CD8 T细胞反应相关,从而将反应集中于有限数量的表位。作为包含在疫苗中的候选药物,针对免疫优势表位的应答表征是新型疫苗开发的关键组成部分。我们以前已经证明,Tp2(49-59)和Tp1(214-224)表位分别在BoLA-A10和BoLA-18 MHC I纯合动物中支配CD8 T细胞反应。在这项研究中,生成了这些表位的肽MHC I四聚体和一个主要的BoLA-A10限制性表位(Tp2(98-106)),以促进准确,快速地枚举表位特异性CD8 T细胞。在验证这些四聚体的过程中,相当大比例的Tp2(49-59)反应性T细胞未能结合四聚体,表明该群体相对于公认的表位而言是异质的。我们证明,Tp2(50-59)代表一个独特的表位,并与Tp(50-59)和Tp(49-59)产生的四聚体没有交叉反应。 Tp2(49-59)和Tp2(50-59)表位使用不同的丝氨酸残基作为N端锚点,以与提出的MHC I分子结合。分子动力学模型预测这两个肽-MHC I复合物采用结构上不同的构象,并且Tcell受体序列分析表明Tp2(49-59)和Tp2(50-59)被非重叠的T细胞受体组成识别。这些数据一起证明尽管Tp2(49-59)和Tp2(50-59)表位仅相差一个残基,但它们形成T细胞受体识别的独特配体。 T. parva特异性CD8 T细胞系的四聚体分析证实了Bop-A18动物中Tp1(214-224)的免疫优势,并且在BoLA-A10动物中显示,Tp2(49-59)表位反应通常比Tp2(50-59)反应,并确认Tp2(98-106)反应占主导。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号